These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Light-Driven Contact Hearing Aid for Broad-Spectrum Amplification: Safety and Effectiveness Pivotal Study.
    Author: Gantz BJ, Perkins R, Murray M, Levy SC, Puria S.
    Journal: Otol Neurotol; 2017 Mar; 38(3):352-359. PubMed ID: 28005723.
    Abstract:
    OBJECTIVE: Demonstrate safety and effectiveness of the light-driven contact hearing aid to support FDA clearance. STUDY DESIGN: A single-arm, open-label investigational-device clinical trial. SETTING: Two private-practice and one hospital-based ENT clinics. PATIENTS: Forty-three subjects (86 ears) with mild-to-severe bilateral sensorineural hearing impairment. INTERVENTION: Bilateral amplification delivered via a light-driven contact hearing aid comprising a Tympanic Lens (Lens) with a customized platform to directly drive the umbo and a behind-the-ear sound processor (Processor) that encodes sound into light pulses to wirelessly deliver signal and power to the Lens. MAIN OUTCOME MEASURES: The primary safety endpoint was a determination of "no change" (PTA4 < 10 dB) in residual unaided hearing at the 120-day measurement interval. The primary efficacy endpoint was improvement in word recognition using NU-6 at the 30-day measurement interval over the baseline unaided case. Secondary efficacy endpoints included functional gain from 2 to 10 kHz and speech-in-noise improvement over the baseline unaided case using both omnidirectional and directional microphones. RESULTS: The results for the 86 ears in the study determined a mean change of -0.40 dB in PTA4, indicating no change in residual hearing (p < 0.0001). There were no serious device- or procedure-related adverse events, or unanticipated adverse events. Word recognition aided with the Earlens improved significantly (p < 0.0001) over the unaided performance, by 35% rationalized arcsine units on average. Mean functional gain was 31 dB across 2 to 10 kHz. The average speech-recognition threshold improvement over the unaided case for the Hearing in Noise Test was 0.75 dB (p = 0.028) and 3.14 dB (p < 0.0001) for the omnidirectional and directional microphone modes, respectively. CONCLUSION: The safety and effectiveness data supported a de novo 510(k) submission that received clearance from the FDA.
    [Abstract] [Full Text] [Related] [New Search]